Decision Algorithm for Ascending Aortic Aneurysm

Study Questions:

Can a decision-making algorithm for triaging patients with ascending aortic aneurysm based on size and symptoms effectively identify patients at risk for aortic-related events?

Methods:

This is a retrospective review of 781 patients with isolated thoracic aortic aneurysm of the root, ascending, and/or arch who were triaged based on a specific decision-making algorithm to surgical intervention or medical management. The algorithm was based on an ascending aortic diameter ≥5 cm or the presence of symptoms; presence of strong family history of aortic aneurysm or aortic-related events, presence of connective tissue disease, and disease of a bicuspid aortic valve were also taken into consideration. Of 607 patients triaged to surgical intervention, 472 underwent surgery promptly, while in 128 patients, surgery was refused by the patient or delayed due to comorbidities (“surgery noncompliant and overwhelming comorbidities”). This group of surgically-triaged but medically managed patients was compared to 181 patients who were triaged to medical therapy (“medical”). Primary outcomes were eventual elective surgical repair, development of an aortic event (dissection, rupture), or death.

Results:

Follow-up was 97.4% complete with mean follow-up 38.9 ± 23 months. The two groups were mostly comparable except for hypertension, chronic kidney disease, and coronary artery disease, which were more prevalent in the “surgery noncompliant and overwhelming comorbidities” group. In the “surgery noncompliant and overwhelming comorbidities” group, 17 patients (13.3%) experienced an aortic-related event and 15 patients (11.8%) had an aortic-related death and while in the “medical” group, three patients (1.7%) experienced an aortic-related event and one patient (0.6%) had an aortic-related death. Kaplan-Meier analysis showed significantly improved survival in the “medical” group for the entire follow-up period (p < 0.001). Multivariable regression of aortic-related events in the two groups showed that maximum aortic diameter was significantly associated with a higher risk of developing an event (hazard ratio, 2.19; p < 0.001).

Conclusions:

A decision-making algorithm for treatment of ascending aortic aneurysm based on maximum diameter ≥5 cm, symptoms, strong family history, connective tissue syndrome, and/or diseased bicuspid aortic valve is clinically effective in determining which patients should undergo surgical intervention and which can be medically managed.

Perspective:

Current multisociety practice guidelines recommend surgical intervention on the ascending aorta at a maximum diameter of ≥5.5 cm. However, based on data from the International Registry of Acute Aortic Dissection, we know that type A dissection frequently occurs at smaller diameters. Indeed, the Aortic Institute at Yale-New Haven Hospital takes a more aggressive stance based on their data, suggesting a hinge point of increased probability of rupture or dissection at 5.25 cm. They operate on aneurysms at ≥5 cm, with good outcomes. Specifically, patients who underwent prompt surgery had a 30-day mortality of just 1%. More importantly, in patients for whom surgery was recommended, the consequences of delayed or no surgery were significant: up to 12% risk of aortic-related death and 13% risk of an aortic-related event. This study suggests that at 5 cm, the risk of surgery is low enough compared to the risk of aortic-related death or events to tilt the scales in favor of surgery. Notably, 38% of the cohort had a positive family history, while only 2.6% had a defined connective tissue syndrome, supporting the familial nature of thoracic aortic aneurysm and the need for ongoing work defining aortic aneurysm genotypes and phenotypes. Limitations as noted by the authors include the retrospective and single-center study design, possible underestimation of aortic events, and bias related to advanced age and comorbidities for which patients did not undergo surgery that may have affected survival.

Clinical Topics: Cardiac Surgery, Invasive Cardiovascular Angiography and Intervention, Prevention, Valvular Heart Disease, Vascular Medicine, Atherosclerotic Disease (CAD/PAD), Aortic Surgery, Cardiac Surgery and VHD, Interventions and Coronary Artery Disease, Interventions and Structural Heart Disease, Interventions and Vascular Medicine, Hypertension

Keywords: Aneurysm, Dissecting, Aortic Aneurysm, Aortic Aneurysm, Thoracic, Aortic Rupture, Cardiac Surgical Procedures, Comorbidity, Connective Tissue Diseases, Coronary Artery Disease, Genotype, Heart Valve Diseases, Hypertension, Phenotype, Renal Insufficiency, Chronic, Thoracic Surgical Procedures


< Back to Listings